Abstract

Background: Pancreatic surgery has been known to have substantial morbidity and mortality rates. Minimally invasive surgery has shown to decrease morbidity and recovery time, which in the context of cancer, will eventually translate into a larger number of patients who will be ready to get adjuvant treatment. We compared three periods of time when we transitioned from an open, hybrid-laparoscopic, and robotic assisted pancreaticoduodenectomy.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call